<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://hdl.handle.net/10451/3767">
    <title>DSpace Collection:</title>
    <link>http://hdl.handle.net/10451/3767</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://hdl.handle.net/10451/7627" />
      </rdf:Seq>
    </items>
    <dc:date>2013-05-20T04:58:32Z</dc:date>
  </channel>
  <item rdf:about="http://hdl.handle.net/10451/7627">
    <title>Electron Ionization Mass Spectrometric Study of Some Substituted 1,3-oxazoles</title>
    <link>http://hdl.handle.net/10451/7627</link>
    <description>Title: Electron Ionization Mass Spectrometric Study of Some Substituted 1,3-oxazoles
Authors: Salgueiro, Pedro; Dias, Catarina; Carreiras, M. Carmo; Borges, Carlos
Abstract: Heterocyclic compounds are widely used as pharmaceuticals. Tacrine (THA) was the first drug approved for the treatment of Alzheimer’s disease (AD) and a great effort has been made to design and synthesize new THA-analogues in order to evaluate their beneficial effects as therapeutic agents in this disease.1-6 Contrasting with the pharmaceutical interest, mass spectrometric studies of these compounds and of some of its precursors, namely the oxazole and oxazole derivatives, are scarce. &#xD;
In order to obtain its structural information, a mass spectrometric study was performed with some 5-amino-2-aryl-4-cyano-1,3-oxazoles (Compounds 1 - 5) using a quadrupole mass spectrometer, equipped with an electron ionization (EI) ion source. &#xD;
Detailed fragmentation pathways have been established for all significant ions, including some fragment ions characteristic of the oxazole family. &#xD;
&#xD;
&#xD;
1. Marco JL, Ríos C, Carreiras MC, Baños JE, Badía A, Vivas NM. Bioorg. Med. Chem. 2001; 9: 727.&#xD;
2. Ros E, Aleu J, Gomez de Aranda I, Canti C, Pang YP, Marsal J, Solsona C. J Neurophysiol. 2001; 86: 183.&#xD;
3. Marco JL, Ríos C, Carreiras MC, Baños JE, Badía A, Vivas NM. Arch. Pharm. Pharm. Med. Chem. 2002; 7: 347.&#xD;
4. Barreiro EJ, Câmara CA, Verli H, Brazilmás L, Castro NG, Cintra WM, Aracava Y, Rodrigues CR, Fraga CAM. Journal of Medicinal Chemistry 2003; 46: 1144.&#xD;
5. Marco JL, Carreiras MC. Mini-Rev. Med. Chem. 2003; 3: 518.&#xD;
6. Marco JL, Ríos C, García AG, Villarroya M, Carreiras MC, Martins C, Eleutério A, Morreale A, Orozco M, Luque FJ. Bioorg. Med. Chem. 2004; 12: 2199.
Description: Comunicação oral sob a forma painel</description>
    <dc:date>2007-11-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

